Synthetic Cannabinoids

A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability

B. T. Burrows, L. R. Watterson, J. Egnatios, Michael Olive

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Synthetic cannabinoids (SCBs) are a large family of molecules that are functionally similar to Δ9-tetrahydrocannabinol, the principal psychoactive constituent found in cannabis. Each new SCB evolves with successive structural modifications while retaining cannabis-like psychoactive effects. As a result, new generations of SCBs have become an established part of the worldwide recreational drug landscape. The existing body of literature on the topic of SCBs as drugs of abuse is growing at an exponential rate, and a comprehensive review of all the literature would be beyond the scope of this chapter. Therefore, what follows is a summary of selected phenomena that have emerged in the cannabinoid literature with respect to the behavioral pharmacology, and abuse liability of SCBs. These phenomena include: (1) cannabinoid receptor subtype 1 (CB1) receptor-mediated characteristic tetrad effects (suppressed locomotion, antinociception, hypothermia, and catalepsy) in laboratory animals; (2) discriminative stimulus effects of SCBs relative to Δ9-tetrahydrocannabinol; and (3) tolerance and cross-tolerance to the effects of SCBs.

Original languageEnglish (US)
Title of host publicationHandbook of Cannabis and Related Pathologies
Subtitle of host publicationBiology, Pharmacology, Diagnosis, and Treatment
PublisherElsevier Inc.
Pages691-699
Number of pages9
ISBN (Electronic)9780128008270
ISBN (Print)9780128007563
DOIs
StatePublished - Jan 24 2017

Fingerprint

Cannabinoids
Pharmacology
Dronabinol
Street Drugs
Cannabis
Catalepsy
Cannabinoid Receptor CB1
Cannabinoid Receptors
Laboratory Animals
Locomotion
Hypothermia

Keywords

  • Agonist
  • CB receptors
  • K2
  • Psychoactive effects
  • Spice
  • Synthetic cannabinoids
  • Tetrad
  • THC

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Burrows, B. T., Watterson, L. R., Egnatios, J., & Olive, M. (2017). Synthetic Cannabinoids: A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability. In Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 691-699). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800756-3.00082-X

Synthetic Cannabinoids : A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability. / Burrows, B. T.; Watterson, L. R.; Egnatios, J.; Olive, Michael.

Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., 2017. p. 691-699.

Research output: Chapter in Book/Report/Conference proceedingChapter

Burrows, BT, Watterson, LR, Egnatios, J & Olive, M 2017, Synthetic Cannabinoids: A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability. in Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., pp. 691-699. https://doi.org/10.1016/B978-0-12-800756-3.00082-X
Burrows BT, Watterson LR, Egnatios J, Olive M. Synthetic Cannabinoids: A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability. In Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc. 2017. p. 691-699 https://doi.org/10.1016/B978-0-12-800756-3.00082-X
Burrows, B. T. ; Watterson, L. R. ; Egnatios, J. ; Olive, Michael. / Synthetic Cannabinoids : A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability. Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment. Elsevier Inc., 2017. pp. 691-699
@inbook{c363a72125084b99bc4458e7aa7b3cc7,
title = "Synthetic Cannabinoids: A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability",
abstract = "Synthetic cannabinoids (SCBs) are a large family of molecules that are functionally similar to Δ9-tetrahydrocannabinol, the principal psychoactive constituent found in cannabis. Each new SCB evolves with successive structural modifications while retaining cannabis-like psychoactive effects. As a result, new generations of SCBs have become an established part of the worldwide recreational drug landscape. The existing body of literature on the topic of SCBs as drugs of abuse is growing at an exponential rate, and a comprehensive review of all the literature would be beyond the scope of this chapter. Therefore, what follows is a summary of selected phenomena that have emerged in the cannabinoid literature with respect to the behavioral pharmacology, and abuse liability of SCBs. These phenomena include: (1) cannabinoid receptor subtype 1 (CB1) receptor-mediated characteristic tetrad effects (suppressed locomotion, antinociception, hypothermia, and catalepsy) in laboratory animals; (2) discriminative stimulus effects of SCBs relative to Δ9-tetrahydrocannabinol; and (3) tolerance and cross-tolerance to the effects of SCBs.",
keywords = "Agonist, CB receptors, K2, Psychoactive effects, Spice, Synthetic cannabinoids, Tetrad, THC",
author = "Burrows, {B. T.} and Watterson, {L. R.} and J. Egnatios and Michael Olive",
year = "2017",
month = "1",
day = "24",
doi = "10.1016/B978-0-12-800756-3.00082-X",
language = "English (US)",
isbn = "9780128007563",
pages = "691--699",
booktitle = "Handbook of Cannabis and Related Pathologies",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Synthetic Cannabinoids

T2 - A Summary of Selected Phenomena With Respect to Behavioral Pharmacology and Abuse Liability

AU - Burrows, B. T.

AU - Watterson, L. R.

AU - Egnatios, J.

AU - Olive, Michael

PY - 2017/1/24

Y1 - 2017/1/24

N2 - Synthetic cannabinoids (SCBs) are a large family of molecules that are functionally similar to Δ9-tetrahydrocannabinol, the principal psychoactive constituent found in cannabis. Each new SCB evolves with successive structural modifications while retaining cannabis-like psychoactive effects. As a result, new generations of SCBs have become an established part of the worldwide recreational drug landscape. The existing body of literature on the topic of SCBs as drugs of abuse is growing at an exponential rate, and a comprehensive review of all the literature would be beyond the scope of this chapter. Therefore, what follows is a summary of selected phenomena that have emerged in the cannabinoid literature with respect to the behavioral pharmacology, and abuse liability of SCBs. These phenomena include: (1) cannabinoid receptor subtype 1 (CB1) receptor-mediated characteristic tetrad effects (suppressed locomotion, antinociception, hypothermia, and catalepsy) in laboratory animals; (2) discriminative stimulus effects of SCBs relative to Δ9-tetrahydrocannabinol; and (3) tolerance and cross-tolerance to the effects of SCBs.

AB - Synthetic cannabinoids (SCBs) are a large family of molecules that are functionally similar to Δ9-tetrahydrocannabinol, the principal psychoactive constituent found in cannabis. Each new SCB evolves with successive structural modifications while retaining cannabis-like psychoactive effects. As a result, new generations of SCBs have become an established part of the worldwide recreational drug landscape. The existing body of literature on the topic of SCBs as drugs of abuse is growing at an exponential rate, and a comprehensive review of all the literature would be beyond the scope of this chapter. Therefore, what follows is a summary of selected phenomena that have emerged in the cannabinoid literature with respect to the behavioral pharmacology, and abuse liability of SCBs. These phenomena include: (1) cannabinoid receptor subtype 1 (CB1) receptor-mediated characteristic tetrad effects (suppressed locomotion, antinociception, hypothermia, and catalepsy) in laboratory animals; (2) discriminative stimulus effects of SCBs relative to Δ9-tetrahydrocannabinol; and (3) tolerance and cross-tolerance to the effects of SCBs.

KW - Agonist

KW - CB receptors

KW - K2

KW - Psychoactive effects

KW - Spice

KW - Synthetic cannabinoids

KW - Tetrad

KW - THC

UR - http://www.scopus.com/inward/record.url?scp=85019300250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019300250&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800756-3.00082-X

DO - 10.1016/B978-0-12-800756-3.00082-X

M3 - Chapter

SN - 9780128007563

SP - 691

EP - 699

BT - Handbook of Cannabis and Related Pathologies

PB - Elsevier Inc.

ER -